TDOC · XBRL financial data

Teladoc Health financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (TDOC's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers661*646642641640*629632626642*614607605
Research and development90*81777277*70696872*686366
General and administrative109*112110114100*113108103108*102104107
Operating income (loss)(35)*(87)(841)(44)(48)*(121)(54)(52)(36)*(62)(37)(28)
Interest income14*14141514*131077*667
Interest expense6*6667*6455*555
Other income (expense)2*(0)(1)2(7)*28(1)0*(0)(2)(0)
Income tax expense (benefit)4*3410*(18)(8)(1)(8)*311
Net income (loss)(29)*(82)(838)(33)(48)*(93)(33)(50)(25)*(64)(39)(27)
Earnings per share, basic USD per share(0.17)*(0.49)(4.92)(0.19)(0.28)*(0.53)(0.19)(0.28)(0.14)*(0.36)(0.21)(0.15)
Earnings per share, diluted USD per share(0.17)*(0.49)(4.92)(0.19)(0.28)*(0.53)(0.19)(0.28)(0.14)*(0.36)(0.21)(0.15)
Weighted average shares, basic millions of shares166*168170171173*174176177178*179181182
Weighted average shares, diluted millions of shares166*168170171173*174176177178*179181182

Balance sheet

CSV

Fiscal quarters (TDOC's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents1,1241,0981,1621,2441,2981,193680726781751774850
Accounts receivable217214218212214233225211193214221231
Inventory303235373838384038322931
Prepaid and other current assets118142131116113138130116107136124114
Total current assets1,4891,4861,5471,6091,6641,6021,0731,0931,1191,1321,1481,226
Property and equipment, net323029282931282727262524
Right-of-use asset403836342727263226242322
Goodwill1,0731,073283283283283283283283283283283
Total assets4,3924,3213,5243,5293,5173,4442,8942,8792,8582,8072,7592,775
Accounts payable443856383352545248453746
Total current liabilities4213899319319429524024054054051,3821,416
Lease liability, non-current434038373234323834323028
Total liabilities2,066—2,0222,0212,0252,0171,4721,4861,4731,4711,4491,480
Accumulated deficit(15,229)(15,311)(16,148)(16,181)(16,230)(16,323)(16,356)(16,405)(16,430)(16,494)(16,533)(16,560)
Total stockholders' equity2,3262,2891,5021,5081,4911,4271,4221,3921,3861,3361,3101,295
Total liabilities and equity4,3924,3213,5243,5293,5173,4442,8942,8792,8582,8072,7592,775
Common shares outstanding (cover page) millions of shares167170171172174175177177178181182182

Cash flows

CSV

Fiscal quarters (TDOC's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)(29)*(82)(838)(33)(48)*(93)(33)(50)(25)*(64)(39)(27)
Stock-based compensation47*4242*34*27*2522*17*16*159*12*
Net cash from operating activities130*989*110*86*1691*99*88*1065*106*
Purchases of property and equipment1*12*2*6*31*2*3*21*1*
Net cash from investing activities(37)*(36)(28)*(31)*(30)*(123)(60)*(49)*(34)*(37)(42)*(31)*
Net cash from financing activities(2)*24*1*2*1(550)*(4)*1*(2)1*0*

Compare with peers

SIC 8011 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8011 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Fewer than three companies fall in that range, so the list adds same-SIC (8011) companies nearest in public float, each marked “added: same SIC”.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
  • A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingRunwayQuarter
Teladoc Health850605106*182.3M— 10-QSep 30, 2026
LifeMD2547(6.9)*48.2M3.6 quarters 10-QJun 30, 2026
Hims & Hers Healthadded: same SIC610753(36)*not reported— 10-QJun 30, 2026
Starling Oncologyadded: same SIC4116112*101.9M— 10-QJun 30, 2026
Airsculpt Technologiesadded: same SIC1943(1.2)*72.1M15.2 quarters 10-QJun 30, 2026
SBC Medical Group Holdingsadded: same SIC1844923*102.8M— 10-QJun 30, 2026
Cardiff Lexingtonadded: same SIC0.22.2(0.7)*15.6M0.3 quarters 10-QJun 30, 2026
HealthLynkedadded: same SIC0not reported(0.4)*3.0M0.0 quarters 10-QJun 30, 2026
Aunaadded: same SIC236year onlyyear onlynot reported— 20-F/ADec 31, 2024

Not investment advice. Not affiliated with the U.S. SEC.